Zoladex Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 02
SKU : PH4245
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the projected growth of the Zoladex market?
The global Zoladex market is expected to reach US$ 1.03 billion by 2030, growing at a CAGR of 1.4% during the forecast period (2023-2030). This growth is driven by factors like rising breast and prostate cancer cases, increasing healthcare expenditure, and advancements in research and development.
Who are the major players in the Zoladex market?
Key players in the global Zoladex market include Tersera Therapeutics, Mithra Pharmaceuticals, Alvogen, AMW GmbH, AstraZeneca, Luye Pharma, Atossa Therapeutics, Sanofi, Fosun Pharma, and Bachem. These companies are actively involved in research, development, manufacturing, and distribution of Zoladex products.
Related Reports
pharmaceuticalsBreast Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 09
Starting from
$4350
pharmaceuticalsProstate Cancer Market Size, Share, Industry, Forecast and outlook 2024-2031
Published: 2024 January 04
Starting from
$4350
pharmaceuticalsEndometriosis Drug Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 26
Starting from
$4350
pharmaceuticalsGnRH Agonists and Antagonists Drugs for Endometriosis Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 05
Starting from
$4350
pharmaceuticalsMetronidazole Capsule Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 16
Starting from
$4350
pharmaceuticalsChronic fatigue syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 28
Starting from
$4350